GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hybio Pharmaceutical Co Ltd (SZSE:300199) » Definitions » Cyclically Adjusted Book per Share

Hybio Pharmaceutical Co (SZSE:300199) Cyclically Adjusted Book per Share : ¥2.77 (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Hybio Pharmaceutical Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Hybio Pharmaceutical Co's adjusted book value per share for the three months ended in Sep. 2024 was ¥0.800. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥2.77 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Hybio Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was -2.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Hybio Pharmaceutical Co was 2.70% per year. The lowest was 1.10% per year. And the median was 1.90% per year.

As of today (2024-12-12), Hybio Pharmaceutical Co's current stock price is ¥13.41. Hybio Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2024 was ¥2.77. Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 4.84.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hybio Pharmaceutical Co was 8.03. The lowest was 1.60. And the median was 3.57.


Hybio Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Hybio Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hybio Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Hybio Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.63 2.72 2.79 2.85 2.81

Hybio Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.85 2.81 2.80 2.77 2.77

Competitive Comparison of Hybio Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Hybio Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hybio Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Sep. 2024 was:

Adj_Book= Book Value per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.8/115.7848*115.7848
=0.800

Current CPI (Sep. 2024) = 115.7848.

Hybio Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201412 1.620 99.000 1.895
201503 2.700 99.900 3.129
201506 2.708 99.500 3.151
201509 2.811 100.500 3.239
201512 2.963 100.600 3.410
201603 3.048 102.200 3.453
201606 3.102 101.400 3.542
201609 3.841 102.400 4.343
201612 3.925 102.600 4.429
201703 4.008 103.200 4.497
201706 3.941 103.100 4.426
201709 4.009 104.100 4.459
201712 4.156 104.500 4.605
201803 4.237 105.300 4.659
201806 4.189 104.900 4.624
201809 4.327 106.600 4.700
201812 3.653 106.500 3.971
201903 3.464 107.700 3.724
201906 3.442 107.700 3.700
201909 3.334 109.800 3.516
201912 2.430 111.200 2.530
202003 2.475 112.300 2.552
202006 2.502 110.400 2.624
202009 2.481 111.700 2.572
202012 1.786 111.500 1.855
202103 1.818 112.662 1.868
202106 1.760 111.769 1.823
202109 1.667 112.215 1.720
202112 1.728 113.108 1.769
202203 1.698 114.335 1.720
202206 1.668 114.558 1.686
202209 1.632 115.339 1.638
202212 1.386 115.116 1.394
202303 1.472 115.116 1.481
202306 1.428 114.558 1.443
202309 1.273 115.339 1.278
202312 0.859 114.781 0.867
202403 0.847 115.227 0.851
202406 0.854 114.781 0.861
202409 0.800 115.785 0.800

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Hybio Pharmaceutical Co  (SZSE:300199) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hybio Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=13.41/2.77
=4.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hybio Pharmaceutical Co was 8.03. The lowest was 1.60. And the median was 3.57.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Hybio Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Hybio Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hybio Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
4th Floor, Office Building, Hanyu Biomedical Park, Middle District, High-tech Industrial Park, Nanshan District, Guangdong Province, Shenzhen, CHN, 518057
Hybio Pharmaceutical Co Ltd is engaged in manufacturing and sale of peptide products. The company's peptide finished dosage products include digestive system agents, immune modulators, hormone and endocrine modulators, antiviral agents, and hemostatic products. It also provides peptide CRO and CMO services, as well as API products.
Executives
Ceng Shao Gui Director
Ceng Shao Bin Director
Ceng Shao Qiang Director
Zhu Wen Feng Directors, Directors, and Executives
Tao An Jin Executives
Wei Hong Executives
Yuan Jian Cheng Directors, executives
Liu Jian Executives
Yang Jun Executives
Executives
Zhu Ning Supervisors
Yang Chun Hai Supervisors
Cai Lei Directors, executives

Hybio Pharmaceutical Co Headlines

No Headlines